Tissue Repair: Given its role in promoting healing and repair, BPC-157 might offer protective benefits in the aftermath of cardiac injury
However, the largest Phase IIb trial involving 536 subjects failed to demonstrate statistically significant weight loss compared to placebo at the primary 12-week endpoint, leading Metabolic Pharmaceuticals to terminate development in 2007
At a dose of 100 g/ml, the extract displayed inhibition on the PGE2, NO, IL-6, TNF-, and IL-1 expression and the activation of p38 MAPK, extracellular signal-regulated kinase (ERK), and JNK in LPS-activated RAW 264.7 cells
(2022) creates a specific problem for dosing frequency
In addition, Zealand and Roche are developing petrelintide as standalone treatment and in combinations, including a program with Roche's incretin candidate CT-388
A favorable or unfavorable tally for one substance does not determine another because each has a different evidence record, proposed clinical uses and quality assessment
